Construction, expression and identification of recombinant adenovirus Ad-VIP in 293 cells

宋敏; 白云; 段文元; 章波; 杨晓亚; 许雪青

您当前的位置：

首页 >

文章列表页 >

Construction, expression and identification of recombinant adenovirus Ad-VIP in 293 cells

更新时间：2026-01-09

- Construction, expression and identification of recombinant adenovirus Ad-VIP in 293 cells
- Journal of Army Medical University Vol. 29, Issue 9, Pages: 806-809(2007)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：
  CLC： R392.11;R394-33;R394.2
- Published：2007
- 稿件说明：
移动端阅览
宋敏,白云,段文元,章波,杨晓亚,许雪青.重组VIP腺病毒载体的构建及其在293细胞的表达[J].陆军军医大学学报(原第三军医大学学报),2007,29(09):806-809.

　SONG Min,BAI Yun,DUAN Wen-yuan,ZHANG Bo,YANG Xiao-ya,XU Xue-qing.Construction, expression and identification of recombinant adenovirus Ad-VIP in 293 cells[J].J Amry Med Univ (J Third Mil Med Univ),2007,29(09):806-809.
宋敏,白云,段文元,章波,杨晓亚,许雪青.重组VIP腺病毒载体的构建及其在293细胞的表达[J].陆军军医大学学报(原第三军医大学学报),2007,29(09):806-809. DOI：

　SONG Min,BAI Yun,DUAN Wen-yuan,ZHANG Bo,YANG Xiao-ya,XU Xue-qing.Construction, expression and identification of recombinant adenovirus Ad-VIP in 293 cells[J].J Amry Med Univ (J Third Mil Med Univ),2007,29(09):806-809. DOI：

摘要

目的构建血管活性肠肽重组腺病毒载体，以期用于体内实验研究。方法利用RT-PCR扩增小鼠大脑VIP mRNA，亚克隆到穿梭质粒pAdTrack-CMV，在pAdeasy内同源重组，筛选阳性克隆

酶切、测序鉴定正确

线性化后脂质体法转染293 细胞进行包装、扩增，利用报告基因EGFP对病毒滴度进行监测。PCR、免疫荧光鉴定pAdeasy-VIP感染293 细胞后VIP基因的表达，ELISA检测重组病毒转染后293细胞上清中的表达。结果测序、酶切证实VIP基因重组腺病毒载体构建成功。RT-PCR，免疫荧光检测pAdeasy-VIP病毒感染的293细胞，均有VIP的表达。与对照组相比，重组病毒转染后293细胞上清中VIP多肽的表达明显增高。结论成功构建了含小鼠VIP基因的重组腺病毒载体，并成功表达VIP多肽。

Abstract

Objective To construct a recombinant adenovirus encoding vasoactive intestinal peptide (VIP) for future gene therapy in vivo. Methods Full length mouse VIP cDNA linked with an internal ribosome entry site (IRES)-EGFP cassette was subcloned into pAdTrack-CMV shuttle plasmid. The product was linearized to mediate homologous recombination with pAdeasy-1 vector in BJ5183 host bacteria. The positive clone was identified by restriction endonuclease digestion and further confirmed by sequencing. The recombinant adenovirus DNA was transfected into 293 cells for packaging and amplification of pAdeasy-VIP virus

which was purified by SARTOBIND Membrane Adsorbers. The expression of VIP was monitored by EGFP fluorescence in infected cells. VIP peptide expression on 293 cells was detected by PCR

immunofluorescent method and ELISA. Results After transfected with adenovirus DNA

infectious virus was only produced to cause cytopathic effect in the permissive cell line 293 but not in the non-permissive cell line HeLa

confirming only replication defective but not wild type virus was generated. The specific expression of mouse pAdeasy-VIP was verified by RT-PCR and immunofluorescent method in 293 cells after infection with pAdeasy-VIP

but not Ad-EGFP

a similarly constructed control virus. pAdeasy-VIP

but not pAd-EGFP

significantly secretes VIP peptide in supernatant. Conclusion We have successfully constructed a recombinant adenovirus pAdeasy-VIP that expresses VIP peptide in vitro.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Construction and identification of recombinant adenovirus vector encoding β-galactosidase with modified AdEasy system

Experimental study of the targeting recombinant adenoviral vector in reversing the mdr hepatocarcinoma cells

Concern over global outbreak of acute severe hepatitis of unknown etiology in children

Role of methyl-CpG-binding domain protein 2 in regulating aquaporin-5 expression in human submandibular gland cells in vitro

Expression and mechanism of rat hyperplasia suppressor gene suppressing growth of rat C6 glioma cells

Related Author

洪思琦

王佚

毕杨

郭振华

梅英

杜伟

丁雄

陈晓光

Related Institution

Institute of Infectious Diseases, Chongqing Key Laboratory of Infectious Diseases Research, First Affiliated Hospital, Army Medical University (Third Military Medical University)

Department of Periodontal Medicine, Affiliated Hospital of Stomatology, Southwest Medical University

Department of Stomatology, First Affiliated Hospital, Army Medical University (Third Military Medical University)

⁰